Advertisement
Screener

BIOGEN INC. (BIIB) Restructuring Charges

2.8 / 5 stars · 68/120 Roast Me

BIOGEN INC. Restructuring Charges

BIOGEN INC. (BIIB) reported Restructuring Charges of $7.90 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:RestructuringCharges · last filed 2026-04-29

  • BIOGEN INC. restructuring charges for the quarter ending 2026-03-31 was $7.90M, a 77.62% decline year-over-year.
  • BIOGEN INC. restructuring charges for the quarter ending 2025-12-31 was $6.60M, a 24.53% increase year-over-year.
  • BIOGEN INC. restructuring charges for the quarter ending 2025-09-30 was $7.40M, a 8.82% increase year-over-year.
  • BIOGEN INC. restructuring charges for the quarter ending 2025-06-30 was -$700.00K, a 110.61% decline year-over-year.
  • BIOGEN INC. restructuring charges for fiscal 2025 was $48.60M, a 60.93% increase from fiscal 2024.
  • BIOGEN INC. restructuring charges for fiscal 2024 was $30.20M, a 86.20% decline from fiscal 2023.
  • BIOGEN INC. restructuring charges for fiscal 2023 was $218.80M, a 66.90% increase from fiscal 2022.
  • BIOGEN INC. restructuring charges for fiscal 2022 was $131.10M.
Period endRestructuring Charges 3 monthRestructuring Charges 6 monthRestructuring Charges 9 monthRestructuring Charges 12 month
2026-03-31$7.90M
10-Q · filed 2026-04-29
$14.50M
derived: sum of 2 quarters · filed 2026-04-29
$21.90M
derived: sum of 3 quarters · filed 2026-04-29
$21.20M
derived: sum of 4 quarters · filed 2026-04-29
2025-12-31$6.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06
$14.00M
derived: sum of 2 quarters · filed 2026-02-06
$13.30M
derived: sum of 3 quarters · filed 2026-02-06
$48.60M
10-K · filed 2026-02-06
2025-09-30$7.40M
10-Q · filed 2025-10-30
$6.70M
derived: sum of 2 quarters · filed 2025-10-30
$42.00M
10-Q · filed 2025-10-30
$47.30M
derived: sum of 4 quarters · filed 2026-04-29
2025-06-30-$700.00K
10-Q · filed 2025-07-31
$34.60M
10-Q · filed 2025-07-31
$39.90M
derived: sum of 3 quarters · filed 2026-04-29
$46.70M
derived: sum of 4 quarters · filed 2026-04-29
2025-03-31$35.30M
10-Q · filed 2026-04-29
$40.60M
derived: sum of 2 quarters · filed 2026-04-29
$47.40M
derived: sum of 3 quarters · filed 2026-04-29
$54.00M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31$5.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06
$12.10M
derived: sum of 2 quarters · filed 2026-02-06
$18.70M
derived: sum of 3 quarters · filed 2026-02-06
$30.20M
10-K · filed 2026-02-06
2024-09-30$6.80M
10-Q · filed 2025-10-30
$13.40M
derived: sum of 2 quarters · filed 2025-10-30
$24.90M
10-Q · filed 2025-10-30
$123.70M
derived: sum of 4 quarters · filed 2026-02-06
2024-06-30$6.60M
10-Q · filed 2025-07-31
$18.10M
10-Q · filed 2025-07-31
$116.90M
derived: sum of 3 quarters · filed 2026-02-06
$192.90M
derived: sum of 4 quarters · filed 2026-02-06
2024-03-31$11.50M
10-Q · filed 2025-05-01
$110.30M
derived: sum of 2 quarters · filed 2026-02-06
$186.30M
derived: sum of 3 quarters · filed 2026-02-06
$220.70M
derived: sum of 4 quarters · filed 2026-02-06
2023-12-31$98.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06
$174.80M
derived: sum of 2 quarters · filed 2026-02-06
$209.20M
derived: sum of 3 quarters · filed 2026-02-06
$218.80M
10-K · filed 2026-02-06
2023-09-30$76.00M
10-Q · filed 2024-10-30
$110.40M
derived: sum of 2 quarters · filed 2024-10-30
$120.00M
10-Q · filed 2024-10-30
$127.00M
derived: sum of 4 quarters · filed 2025-02-12
2023-06-30$34.40M
10-Q · filed 2024-08-01
$44.00M
10-Q · filed 2024-08-01
$51.00M
derived: sum of 3 quarters · filed 2025-02-12
$66.40M
derived: sum of 4 quarters · filed 2025-02-12
2023-03-31$9.60M
10-Q · filed 2024-04-24
$16.60M
derived: sum of 2 quarters · filed 2025-02-12
$32.00M
derived: sum of 3 quarters · filed 2025-02-12
$102.60M
derived: sum of 4 quarters · filed 2025-02-12
2022-12-31$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
$22.40M
derived: sum of 2 quarters · filed 2025-02-12
$93.00M
derived: sum of 3 quarters · filed 2025-02-12
$131.10M
10-K · filed 2025-02-12
2022-09-30$15.40M
10-Q · filed 2023-11-08
$86.00M
derived: sum of 2 quarters · filed 2023-11-08
$124.10M
10-Q · filed 2023-11-08
$124.10M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$70.60M
10-Q · filed 2023-07-25
$108.70M
10-Q · filed 2023-07-25
$108.70M
derived: sum of 3 quarters · filed 2024-02-14
$108.70M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$38.10M
10-Q · filed 2023-04-25
$38.10M
derived: sum of 2 quarters · filed 2024-02-14
$38.10M
derived: sum of 3 quarters · filed 2024-02-14
$38.10M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$0.00
derived: sum of 2 quarters · filed 2024-02-14
$0.00
derived: sum of 3 quarters · filed 2024-02-14
$0.00
10-K · filed 2024-02-14
2021-09-30$0.00
10-Q · filed 2022-10-25
$0.00
derived: sum of 2 quarters · filed 2022-10-25
$0.00
10-Q · filed 2022-10-25
$0.00
derived: sum of 4 quarters · filed 2023-02-15
2021-06-30$0.00
10-Q · filed 2022-07-20
$0.00
10-Q · filed 2022-07-20
$0.00
derived: sum of 3 quarters · filed 2023-02-15
$0.00
derived: sum of 4 quarters · filed 2023-02-15
2021-03-31$0.00
10-Q · filed 2022-05-03
$0.00
derived: sum of 2 quarters · filed 2023-02-15
$0.00
derived: sum of 3 quarters · filed 2023-02-15
$0.00
derived: sum of 4 quarters · filed 2023-02-15
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15
$0.00
derived: sum of 2 quarters · filed 2023-02-15
$0.00
derived: sum of 3 quarters · filed 2023-02-15
$0.00
10-K · filed 2023-02-15
2020-09-30$0.00
10-Q · filed 2020-10-21
$0.00
derived: sum of 2 quarters · filed 2020-10-21
$0.00
10-Q · filed 2020-10-21
$0.00
derived: sum of 4 quarters · filed 2022-02-03
2020-06-30$0.00
10-Q · filed 2020-07-22
$0.00
10-Q · filed 2020-07-22
$0.00
derived: sum of 3 quarters · filed 2022-02-03
$300.00K
derived: sum of 4 quarters · filed 2022-02-03
2020-03-31$0.00
10-Q · filed 2020-04-23
$0.00
derived: sum of 2 quarters · filed 2022-02-03
$300.00K
derived: sum of 3 quarters · filed 2022-02-03
$1.10M
derived: sum of 4 quarters · filed 2022-02-03
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03
$300.00K
derived: sum of 2 quarters · filed 2022-02-03
$1.10M
derived: sum of 3 quarters · filed 2022-02-03
$1.50M
10-K · filed 2022-02-03
2019-09-30$300.00K
10-Q · filed 2020-10-21
$1.10M
derived: sum of 2 quarters · filed 2020-10-21
$1.50M
10-Q · filed 2020-10-21
$4.30M
derived: sum of 4 quarters · filed 2021-02-03
2019-06-30$800.00K
10-Q · filed 2020-07-22
$1.20M
10-Q · filed 2020-07-22
$4.00M
derived: sum of 3 quarters · filed 2021-02-03
$10.00M
derived: sum of 4 quarters · filed 2021-02-03
2019-03-31$400.00K
10-Q · filed 2020-04-23
$3.20M
derived: sum of 2 quarters · filed 2021-02-03
$9.20M
derived: sum of 3 quarters · filed 2021-02-03
$10.80M
derived: sum of 4 quarters · filed 2021-02-03
2018-12-31$2.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03
$8.80M
derived: sum of 2 quarters · filed 2021-02-03
$10.40M
derived: sum of 3 quarters · filed 2021-02-03
$12.00M
10-K · filed 2021-02-03
2018-09-30$6.00M
10-Q · filed 2019-10-22
$7.60M
derived: sum of 2 quarters · filed 2019-10-22
$9.20M
10-Q · filed 2019-10-22
$10.10M
derived: sum of 4 quarters · filed 2020-02-06
2018-06-30$1.60M
10-Q · filed 2019-07-24
$3.20M
10-Q · filed 2019-07-24
$4.10M
derived: sum of 3 quarters · filed 2020-02-06
$4.10M
derived: sum of 4 quarters · filed 2020-02-06
2018-03-31$1.60M
10-Q · filed 2019-04-24
$2.50M
derived: sum of 2 quarters · filed 2020-02-06
$2.50M
derived: sum of 3 quarters · filed 2020-02-06
$2.50M
derived: sum of 4 quarters · filed 2020-02-06
2017-12-31$900.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06
$900.00K
derived: sum of 2 quarters · filed 2020-02-06
$900.00K
derived: sum of 3 quarters · filed 2020-02-06
$900.00K
10-K · filed 2020-02-06
2017-09-30$0.00
10-Q · filed 2018-10-23
$0.00
derived: sum of 2 quarters · filed 2018-10-23
$0.00
10-Q · filed 2018-10-23
$11.80M
derived: sum of 4 quarters · filed 2019-02-06
2017-06-30$0.00
10-Q · filed 2018-07-24
$0.00
10-Q · filed 2018-07-24
$11.80M
derived: sum of 3 quarters · filed 2019-02-06
$23.40M
derived: sum of 4 quarters · filed 2019-02-06
2017-03-31$0.00
10-Q · filed 2018-04-24
$11.80M
derived: sum of 2 quarters · filed 2019-02-06
$23.40M
derived: sum of 3 quarters · filed 2019-02-06
$23.40M
derived: sum of 4 quarters · filed 2019-02-06
2016-12-31$11.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06
$23.40M
derived: sum of 2 quarters · filed 2019-02-06
$23.40M
derived: sum of 3 quarters · filed 2019-02-06
$33.10M
10-K · filed 2019-02-06
2016-09-30$11.60M
10-Q · filed 2017-10-24
$11.60M
derived: sum of 2 quarters · filed 2017-10-24
$21.30M
10-Q · filed 2017-10-24
$114.70M
derived: sum of 4 quarters · filed 2017-10-24
2016-06-30$0.00
10-Q · filed 2017-07-25
$9.70M
10-Q · filed 2017-07-25
$103.10M
derived: sum of 3 quarters · filed 2017-07-25
$103.10M
derived: sum of 4 quarters · filed 2017-07-25
2016-03-31$9.70M
10-Q · filed 2017-04-25
$103.10M
derived: sum of 2 quarters · filed 2017-04-25
$103.10M
derived: sum of 3 quarters · filed 2017-04-25
$103.10M
derived: sum of 4 quarters · filed 2017-04-25
2015-12-31$93.40M
10-Q · filed 2016-07-21
$93.40M
derived: sum of 2 quarters · filed 2016-10-26
$93.40M
derived: sum of 3 quarters · filed 2016-10-26
$93.40M
10-K · filed 2018-02-01
2015-09-30$0.00
10-Q · filed 2016-10-26
$0.00
derived: sum of 2 quarters · filed 2016-10-26
$0.00
10-Q · filed 2016-10-26
2015-06-30$0.00
10-Q · filed 2016-07-21
$0.00
10-Q · filed 2016-07-21
2015-03-31$0.00
10-Q · filed 2016-04-21
2014-12-31$0.00
10-K · filed 2017-02-02
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03
$0.00
derived: sum of 2 quarters · filed 2016-02-03
$0.00
derived: sum of 3 quarters · filed 2016-02-03
$0.00
10-K · filed 2016-02-03
2013-09-30$0.00
10-Q · filed 2013-10-28
$0.00
derived: sum of 2 quarters · filed 2013-10-28
$0.00
10-Q · filed 2013-10-28
$0.00
derived: sum of 4 quarters · filed 2015-02-04
2013-06-30$0.00
10-Q · filed 2013-07-25
$0.00
10-Q · filed 2013-07-25
$0.00
derived: sum of 3 quarters · filed 2015-02-04
$803.00K
derived: sum of 4 quarters · filed 2015-02-04
2013-03-31$0.00
10-Q · filed 2013-04-25
$0.00
derived: sum of 2 quarters · filed 2015-02-04
$803.00K
derived: sum of 3 quarters · filed 2015-02-04
$1.94M
derived: sum of 4 quarters · filed 2015-02-04
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04
$803.00K
derived: sum of 2 quarters · filed 2015-02-04
$1.94M
derived: sum of 3 quarters · filed 2015-02-04
$2.23M
10-K · filed 2015-02-04
2012-09-30$803.00K
10-Q · filed 2013-10-28
$1.94M
derived: sum of 2 quarters · filed 2013-10-28
$2.23M
10-Q · filed 2013-10-28
$2.86M
derived: sum of 4 quarters · filed 2014-02-06
2012-06-30$1.14M
10-Q · filed 2013-07-25
$1.42M
10-Q · filed 2013-07-25
$2.06M
derived: sum of 3 quarters · filed 2014-02-06
$3.86M
derived: sum of 4 quarters · filed 2014-02-06
2012-03-31$283.00K
10-Q · filed 2013-04-25
$919.00K
derived: sum of 2 quarters · filed 2014-02-06
$2.72M
derived: sum of 3 quarters · filed 2014-02-06
$2.72M
derived: sum of 4 quarters · filed 2014-02-06
2011-12-31$636.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06
$2.44M
derived: sum of 2 quarters · filed 2014-02-06
$2.44M
derived: sum of 3 quarters · filed 2014-02-06
$19.03M
10-K · filed 2014-02-06
2011-09-30$1.80M
10-Q · filed 2012-10-25
$1.80M
derived: sum of 2 quarters · filed 2012-10-25
$18.39M
10-Q · filed 2012-10-25
$93.59M
derived: sum of 4 quarters · filed 2012-10-25
2011-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-24
$16.59M
10-Q · filed 2012-07-24
$91.79M
derived: sum of 3 quarters · filed 2012-07-24
2011-03-31$16.59M
10-Q · filed 2012-05-01
$91.79M
derived: sum of 2 quarters · filed 2012-05-01
2010-12-31$75.20M
10-K · filed 2012-02-03
$75.15M
10-K · filed 2013-02-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29